83 related articles for article (PubMed ID: 21519798)
21. CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice.
Niu M; Wu S; Mao L; Yang Y
Traffic; 2013 Oct; 14(10):1042-52. PubMed ID: 23829533
[TBL] [Abstract][Full Text] [Related]
22. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
23. The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage.
van der Watt PJ; Leaner VD
Biochim Biophys Acta; 2011 Jul; 1809(7):316-26. PubMed ID: 21683812
[TBL] [Abstract][Full Text] [Related]
24. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover.
Henderson BR
Nat Cell Biol; 2000 Sep; 2(9):653-60. PubMed ID: 10980707
[TBL] [Abstract][Full Text] [Related]
25. Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.
Floyd HS; Farnsworth CL; Kock ND; Mizesko MC; Little JL; Dance ST; Everitt J; Tichelaar J; Whitsett JA; Miller MS
Carcinogenesis; 2005 Dec; 26(12):2196-206. PubMed ID: 16051643
[TBL] [Abstract][Full Text] [Related]
26. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.
Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H
Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158
[TBL] [Abstract][Full Text] [Related]
27. Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.
Zhang K; Wang M; Tamayo AT; Shacham S; Kauffman M; Lee J; Zhang L; Ou Z; Li C; Sun L; Ford RJ; Pham LV
Exp Hematol; 2013 Jan; 41(1):67-78.e4. PubMed ID: 22986101
[TBL] [Abstract][Full Text] [Related]
28. The BRO proteins of Bombyx mori nucleopolyhedrovirus are nucleocytoplasmic shuttling proteins that utilize the CRM1-mediated nuclear export pathway.
Kang W; Kurihara M; Matsumoto S
Virology; 2006 Jun; 350(1):184-91. PubMed ID: 16483627
[TBL] [Abstract][Full Text] [Related]
29. The differential effects of mutant p53 alleles on advanced murine lung cancer.
Jackson EL; Olive KP; Tuveson DA; Bronson R; Crowley D; Brown M; Jacks T
Cancer Res; 2005 Nov; 65(22):10280-8. PubMed ID: 16288016
[TBL] [Abstract][Full Text] [Related]
30. Subcellular Distribution of p53 by the p53-Responsive lncRNA
Mitra S; Muralidharan SV; Di Marco M; Juvvuna PK; Kosalai ST; Reischl S; Jachimowicz D; Subhash S; Raimondi I; Kurian L; Huarte M; Kogner P; Fischer M; Johnsen JI; Mondal T; Kanduri C
Cancer Res; 2021 Mar; 81(6):1457-1471. PubMed ID: 33372039
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage.
Cai X; Liu X
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16958-63. PubMed ID: 18952844
[TBL] [Abstract][Full Text] [Related]
32. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [corrected] induces CRM1-dependent p53 nuclear accumulation in human bronchial epithelial cells.
Chen L; Shao C; Cobos E; Wang JS; Gao W
Toxicol Sci; 2010 Jul; 116(1):206-15. PubMed ID: 20421341
[TBL] [Abstract][Full Text] [Related]
33. DNA damage induces p53-dependent BRCA1 nuclear export.
Feng Z; Kachnic L; Zhang J; Powell SN; Xia F
J Biol Chem; 2004 Jul; 279(27):28574-84. PubMed ID: 15087457
[TBL] [Abstract][Full Text] [Related]
34. Lung tumor promotion by curcumin.
Dance-Barnes ST; Kock ND; Moore JE; Lin EY; Mosley LJ; D'Agostino RB; McCoy TP; Townsend AJ; Miller MS
Carcinogenesis; 2009 Jun; 30(6):1016-23. PubMed ID: 19359593
[TBL] [Abstract][Full Text] [Related]
35. Interplay between p53-family, their regulators, and PARPs in DNA repair.
Emami S
Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):98-104. PubMed ID: 21177056
[TBL] [Abstract][Full Text] [Related]
36. Trans-chalcone increases p53 activity via DNAJB1/HSP40 induction and CRM1 inhibition.
Silva G; Marins M; Chaichanasak N; Yoon Y; Fachin AL; Pinhanelli VC; Regasini LO; Dos Santos MB; Ayusso GM; Marques BC; Wu WW; Phue JN; Shen RF; Baek SJ
PLoS One; 2018; 13(8):e0202263. PubMed ID: 30118500
[TBL] [Abstract][Full Text] [Related]
37. Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors.
Dance-Barnes ST; Kock ND; Floyd HS; Moore JE; Mosley LJ; D'Agostino RB; Pettenati MJ; Miller MS
Toxicol Appl Pharmacol; 2008 Aug; 231(1):77-84. PubMed ID: 18565564
[TBL] [Abstract][Full Text] [Related]
38. Regulation of p53 tetramerization and nuclear export by ARC.
Foo RS; Nam YJ; Ostreicher MJ; Metzl MD; Whelan RS; Peng CF; Ashton AW; Fu W; Mani K; Chin SF; Provenzano E; Ellis I; Figg N; Pinder S; Bennett MR; Caldas C; Kitsis RN
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20826-31. PubMed ID: 18087040
[TBL] [Abstract][Full Text] [Related]
39. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.
van der Watt PJ; Maske CP; Hendricks DT; Parker MI; Denny L; Govender D; Birrer MJ; Leaner VD
Int J Cancer; 2009 Apr; 124(8):1829-40. PubMed ID: 19117056
[TBL] [Abstract][Full Text] [Related]
40. CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.
Liu X; Chong Y; Tu Y; Liu N; Yue C; Qi Z; Liu H; Yao Y; Liu H; Gao S; Niu M; Yu R
J Hematol Oncol; 2016 Oct; 9(1):108. PubMed ID: 27733172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
